Quarterly ResultAug 12, 2026, 07:06 AM
Kamada Q2 Revenue $54.9M, H1 Revenue $100.2M; Reaffirms 2026 Guidance
AI Summary
Kamada Ltd. reported record-high financial results for the second quarter and first half of 2026, driven by strong demand for its proprietary products. Second quarter revenues increased 23% year-over-year to $54.9 million, with adjusted EBITDA up 29% to $14.1 million. For the first half, revenues grew 13% to $100.2 million and adjusted EBITDA rose 14% to $25.7 million. The company also secured a new three-year, $50 million strategic plasma supply agreement and reaffirmed its full-year 2026 guidance.
Key Highlights
- Q2 2026 Revenues reached a record-high of $54.9 million, up 23% year-over-year.
- Q2 2026 Adjusted EBITDA was $14.1 million, a 29% increase year-over-year.
- First Half 2026 Revenues were a record-high $100.2 million, up 13% year-over-year.
- First Half 2026 Adjusted EBITDA was $25.7 million, up 14% year-over-year.
- Secured a three-year strategic sales agreement of approximately $50 million to supply plasma.
- Generated $17.8 million in cash from operating activities during the first six months of 2026.
- Reaffirmed 2026 annual guidance: Revenues $200M-$205M and Adjusted EBITDA $50M-$53M.
Price Impact
More from KMDA